Merchavia Holdings and Investments Ltd (MRHL) Fair Value & Analysis
Healthcare · Il · Market cap 33.3M ILA
Risks
Fair value as of: Aug 27, 2026
From 1 valuation models · updated today
Share price −10.1% over the past month.
Below-average quality, and trading another 221% above our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (0.7300 ILA). The favourable scenario is already priced in.
- Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (0.3700 ILA to 0.7300 ILA) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 27, 2026.
How to read this chart
60‑month range 0.5870 ILA – 4.18 ILA · fair‑value band 0.3700 ILA – 0.7300 ILA · the 1.57 ILA price screens above the 0.4900 ILA fair value. Dashed = 300-day average. As of Aug 27, 2026.
Analysis
Merchavia Holdings and Investments Ltd (MRHL) currently trades at 1.57 ILA, while our model-based Fair Value estimate is 0.4900 ILA, implying the stock looks roughly 68.9% overvalued today. The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 44.0K ILA. It earns a return on equity of -52.4%. The stock trades on a trailing P/E of 22.5. Fundamentals as of Aug 27, 2026
Our scenario range runs from 0.3700 ILA (bear case) to 0.7300 ILA (bull case); at 1.57 ILA, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -69%, MRHL screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when MRHL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 27, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 36 · Market factors (momentum, volatility) 54
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Merchavia Holdings and Investments Ltd is a principal investment firm. The firm prefers to invest in companies doing business in technology, med-tech, medicine, medical products, medical solutions and medical distribution related sectors. It prefers to invest in companies related to Cleveland Clinic.
Full company description
Merchavia Holdings and Investments Ltd is a principal investment firm. The firm prefers to invest in companies doing business in technology, med-tech, medicine, medical products, medical solutions and medical distribution related sectors. It prefers to invest in companies related to Cleveland Clinic. Merchavia Holdings and Investments Ltd was founded in 1972 and is based in Bnei Brak, Israel with additional office in Bnei Brak, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Merchavia Holdings and Investments Ltd reported revenue of 415K ILA in FY2025 versus 10.6M ILA in FY2021, a compound −55.5%/yr. Reported net income was −10.2M ILA in FY2025.
MRHL screens 69% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 266 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 27, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 237.80 SAR | 112.37 SAR | -53% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| DaVita Inc DVA | $180.06 | $186.49 | +4% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,818 | ₹2,955 | -66% |
| Fresenius Medical Care AG FME | €40.89 | €71.28 | +74% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,005 | ₹284.87 | -72% |
Compare Merchavia Holdings and Investments Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Merchavia Holdings and Investments Ltd (MRHL) overvalued or undervalued?
What is the fair value of MRHL?
What is the quality score of MRHL?
What is the revenue of Merchavia Holdings and Investments Ltd (MRHL)?
What is the net profit margin of MRHL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Watch Merchavia Holdings and Investments Ltd in the live analysis
One click puts Merchavia Holdings and Investments Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.